drugset / Trial / NCT04713904
Bioavailability of Clormadinone/Ethinyl Estradiol Tablets 2 mg/0.02 mg With Regards to Reference Product
RandomizedCrossoverOpen-labelBasic science
Summary
The study will be performed at a single site with 38 subjects. Participantswill take 2 tablets of the test product and reference product in 2 periods and 2 sequences (either test after reference or reference after test). There will be a washout of at least 14 days between each study period.
Timeline
- Start
- 2021-01-16
- Primary completion
- 2021-01-16
- Completion
- 2021-02-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Clormadinone | Unknown | 2 mg | — |
| Comparator | ethinyl estradiol | Small molecule | 0.02 mg | — |
Indications
No indication recorded.